PCR203 Quality-Adjusted Time Without Symptoms or Toxicity Q-TWiST Estimates in Previously Treated HER2-Positive Biliary Tract Carcinoma (BTC) Using the Zanidatamab HERIZON-BTC-01 Study
Abstract
Authors
Will Battershill Anthony Hatswell Kurt Taylor Javier Sabater Sally Bowditch Junji Lin Phillip Garfin Xiaotian Wu Wayne Su John Bridgewater